Sapc-dops nanovesicles for treating glioblastoma multiforme
Ended Block Grant Awarded
- Award ID
- R43CA136017
- Recipient
-
Bexion Pharmaceuticals, Inc. UEI HJPDQTK95NS8
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $273,138
Award facts
- Assistance listing
- 93.395 Cancer Treatment Research
- Completion date
- Place of performance
- Cincinnati, OH 45219, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43CA136017?
R43CA136017 was awarded to Bexion Pharmaceuticals, Inc. by National Institutes of Health (Department of Health and Human Services) on September 25, 2008.
How much is award R43CA136017 worth?
$273,138 has been obligated on R43CA136017.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award